Plunkett Research Online: Molecular Pharmacology USA Ltd.

MOLECULAR PHARMACOLOGY USA LTD. (MLPH:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Molecular Pharmacology USA Ltd. is a development stage biotechnology company, through its subsidiary is engaged in the business of developing and commercializing a new analgesic and anti-inflammatory molecule known as Tripeptofen. Tripeptofen is likely to appear in a new group of products suitable f.....



Molecular Pharmacology USA Ltd.
Ticker: MLPH
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 894433011
Fax:
Address: Drug Discovery Centre
284 Oxford Street
Leederville
Perth, WA 6007 Australia

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmacies and Drug Stores
ContactsDescription

Molecular Pharmacology USA Ltd. is a development stage biotechnology company, through its subsidiary is engaged in the business of developing and commercializing a new analgesic and anti-inflammatory molecule known as Tripeptofen. Tripeptofen is likely to appear in a new group of products suitable f.....See More See More

Auditor: James Stafford, Inc.
Legal Advisor: Venture Law Corporation
$USD, In whole numbers,
except marked * or %
201420132012201120102009
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: